Xojo 2025r1 Launches with Linux ARM Support, Web Drag and Drop and Direct App Store Submission
AUSTIN, Texas, March 25, 2025 /PRNewswire/ -- Xojo, Inc., the developers behind…
Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts
Q4 2024 revenue of $1.5 million in pharma services; full year revenue…
Veefin Group to Strengthen Portfolio with Strategic Investment in White Rivers Media
Veefin Group has announced a strategic investment in White Rivers Media (WRM),…
ExoraPad Presale Explodes, Targets A 10X Surge Upon Launch
CORK, Ireland, March 22, 2025 (GLOBE NEWSWIRE) -- ExoraPad, the AI-powered IDO…
KODA Integrates with Bitcoin Staking Chain Core, Paving the Way for Increased Institutional Adoption in Korea
Seoul, South Korea, March 21, 2025 (GLOBE NEWSWIRE) -- KODA, the largest…
Dialysis, Transplants & Beyond: Experts at Manipal Hospital Hebbal Raise Awareness on Kidney Health
BENGALURU, India, March 21, 2025 /PRNewswire/ -- Nearly 10% of Indians suffer…
Allstate India Enhances Mental Health Resources for Employees
BANGALORE, India, March 19, 2025 /PRNewswire/ -- To further enhance employee well-being, Allstate…
Novartis receives third FDA approval for oral Fabhalta (iptacopan) the first and only treatment approved in C3 glomerulopathy (C3G)
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first…
How to Invest in Ethereum. Earn Cryptocurrency with the Best Cloud Mining in 2025
As a leading cloud mining platform, ICOminer offers stable daily returns with…
CrushOn.AI Unveils NSFW AI Girlfriend Chat in 2025
LOS ANGELES, March 14, 2025 (GLOBE NEWSWIRE) -- CrushOn.AI is still making…